Prenatal Screening

Prenatal Screening involves a combination of blood tests and ultrasounds to assess the risk of certain genetic conditions and chromosomal abnormalities in the developing baby. These non-invasive tests, typically done in the first and second trimesters, help expectant parents make informed decisions and prepare for the health and care needs of their baby

Combined biochemical screening double screening for Trisomy

Combined tests screening double screening for Trisomy 21/13/18 (11-14weeks) includes a series of tests to assess the risk of chromosomal abnormalities in your baby. Our screening process helps you make informed decisions about your pregnancy.

Quadruple screening for Trisomy

Quadruple screening for Trisomy 21/13/18 (15-22weeks). Quadruple Tests Screening offers further evaluation for specific chromosomal disorders. It provides additional data to refine your understanding of your baby’s health.

Preeclampsia Screening

Pre-Eclampsia Monitoring focuses on the early detection and management of this potentially serious pregnancy complication. Our proactive approach safeguards your health and your baby’s well-being.

Non-Invasive Prenatal Screening (NIPT/NIPS)

NIPT is a highly accurate and minimally invasive genetic testing method. It provides comprehensive information about your baby’s genetic health, offering valuable insights while minimizing risk.